Reaction profile

The FDA adverse-event record for cholecystitis

42 FDA reports name cholecystitis, a lower-volume reaction in the CVM extract (VeDDRA 479). Plate stamps and neighbourhood peers follow.

#1825 of 2,481
by report volume (all reactions)
42
reports citing this reaction
40.5%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Cholecystitis has 42 reports now versus 42 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Cholecystitis changes

FDA AER · VeDDRA plate

Code 479 VOL-TRACE

VOL-TRACE · DEATH-HOT · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 42 reports
  • DEATH-HOT 40.5%
  • MID-PACK #1825/2481
  • PHOTO-FINISH Allergy to food
  • SPECIES-DOG Dog · 34
  • DRUG-LEAD Maropitant Citrate · 6
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Allergy to food (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Cholecystitis

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Allergy to food · near42Asystole · near42Cholecystitis · this reaction42Cutaneous emphysema · near42Digestive tract stasis · near42Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Cholecystitis

Cholecystitis: high death-coded share in the FDA AER plate

Signature read: Cholecystitis's 40.5% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 42 named reports in the openFDA extract. Death-coded share is upper-third: 17 of 42 reports (40.5% of named reports). Nearest volume peer: Allergy to food (±0 reports). Lead species Dog (34). Lead co-reported drug Maropitant Citrate (6).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 34
Cat 7
Cattle 1

Breeds Most Affected

Domestic Shorthair 5
Retriever - Labrador 4
Terrier - Yorkshire 3
Dachshund (unspecified) 2
Terrier (unspecified) 2
Terrier - West Highland White 2
Shih Tzu 2
Rottweiler 2
Domestic Longhair 2
Boxer (German Boxer) 1

Associated Drugs

Maropitant Citrate 6
Ivermectin + Pyrantel As Pamoate Salt 5
Carprofen 4
Gabapentin 4
Bedinvetmab 4
Cefovecin 3
Mirtazapine 3
Oclacitinib Maleate 3
Moxidectin 3
Trazodone 3
Fuzapladib Sodium 3
Maropitant 2
Spinosad 2
Dexmedetomidine Hydrochloride 2
Meloxicam 2
Ampicillin 2
Enrofloxacin 2
Trilostane 2
Ursodiol 2
Isotonic Fluids 2

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Cholecystitis (#1825 of 2,481 by report volume); death-coded 40.5%. PlainBreed reaction plate · death-coded share stamp 40.5% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →